NCT00140400View on ClinicalTrials.gov

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 1999

Study Completion Date

January 31, 2001

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Sponsors

Lead Sponsor

Cell Genesys
All Listed Sponsors
lead

Cell Genesys

INDUSTRY